Redirecting to https://www.manilatimes.net/2026/10/19/tmt-newswire/globenewswire/quanta-therapeutics-announces-presentation-of-qtx3034-clinical-combination-data-with-anti-egfr-and-chemotherapy-in-colorectal-cancer-crc-at-esmo-and-fast-track-designation-for-patients-with-kras-g12d-mutations/2448532